Spectrum and immunovirological determinants of tumours among people living with HIV in Uganda: A retrospective cross sectional study from a specialised HIV centre, 2017–2026

Joseph Mwaka, Conrad Sserunjogi, Jesca Natalayi · 2026

Read Spectrum and immunovirological determinants of tumours among people living with HIV in Uganda: A retrospective cross sectional study from a specialised HIV centre, 2017–2026 by Joseph Mwaka, Conrad Sserunjogi, Jesca Natalayi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358066.txt.

Description

Joseph Mwaka, Conrad Sserunjogi, and Jesca Natalayi catalogue the tumours found in patients at a specialized HIV centre in Kampala, in PLOS ONE in 2026. They reviewed two hundred nineteen tumour records at Mildmay Hospital, spanning 2017 into 2026. For each growth they noted whether it was malignant. They also recorded the patient's immune status and virus control at diagnosis, in the modern era of effective HIV treatment.

Nearly two thirds of the tumours were malignant, and Kaposi sarcoma alone supplied almost half of the cancers. Most patients had their virus suppressed at diagnosis, yet over half of those suppressed cases were still malignant. Cancer clustered in patients who had started treatment late: low immune cell counts, advanced disease stage, and fewer months on therapy before the tumour appeared. The authors caution these are unadjusted patterns, but they set a baseline for a planned prospective cancer cohort at the centre.

Catalog record

CREATORJoseph Mwaka, Conrad Sserunjogi, Jesca Natalayi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43780
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0358066

Browse the full library · About the Tower of Babel